Bioventus LLC expanded its European footprint by officially launching its company and products in Italy. The company, which opened its International Headquarters in the Netherlands last month, delivers clinically proven, cost-effective solutions that help people recover and heal quickly and safely. Augusti explained that Bioventus products available in Italy will switch from their current Smith & Nephew labeling to Bioventus.

The products themselves will not change and will remain the same clinically proven, safe, effective solutions that physicians and patients know and trust. This includes: EXOGEN Ultrasound Bone Healing System – a product indicated in Europe to accelerate the healing of recent fractures and to heal bones that have either delayed healing (delayed unions) or stopped healing completely (non-unions). EXOGEN has been shown to heal 86% of non-unions fractures and accelerate the healing of fresh fractures up to 38% faster.

DUROLANE – a single-injection, 3ml, joint-fluid treatment to relieve mild to moderate osteoarthritis (OA) pain of all sizes of synovial joints. A 1ml version of the product, DUROLANE SJ, is also available and indicated for treatment of OA pain in small joints.